Two senior Food and Drug Administration (FDA) vaccine regulators are planning to leave the agency in the coming weeks, said the FDA on Tuesday. The regulator is “confident in the expertise and ability of our staff to continue our critical public health work, including evaluating COVID-19 vaccines,” FDA spokeswoman Stephanie Caccomo said in a statement to news outlets in confirming the planned departures of Dr. Marion Gruber, the head of the FDA’s Office of Vaccines Research and Review (OVRR), and Gruber’s deputy, Dr. Philip Krause. FDA acting Director Janet Woodcock confirmed to medical news website Endpoints News of their departures and said she wishes them well in their future endeavors. Jeffrey Zients, the White House COVID-19 team coordinator, told reporters in a virtual briefing that the booster decision was made by “the nation’s leading public health officials,” including Dr. Anthony Fauci and Dr. Rochelle Walensky. The OVRR, according to the FDA, is …